SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-016569
Filing Date
2024-06-12
Accepted
2024-06-12 20:00:06
Documents
1
Period of Report
2024-06-11

Document Format Files

Seq Description Document Type Size
1 form4-06122024_080602.html 4  
1 form4-06122024_080602.xml 4 8686
  Complete submission text file 0001415889-24-016569.txt   10227
Mailing Address 1167 MASSACHUSETTS AVENUE ARLINGTON MA 02476
Business Address 1167 MASSACHUSETTS AVENUE ARLINGTON MA 02476 781-996-5252
KALA BIO, Inc. (Issuer) CIK: 0001479419 (see all company filings)

IRS No.: 270604595 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O 1LIFE HEALTHCARE, INC. ONE EMBARCADERO CENTER, SUITE 1900 SAN FRANCISCO CA 94111
Business Address
Blumenkranz Mark S. (Reporting) CIK: 0001614869 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38150 | Film No.: 241039759